Discovery of Novel Pyrazol-5-yl-benzamide Derivatives Containing a Thiocyanato Group as Broad-Spectrum Fungicidal Candidates

被引:8
|
作者
Li, Yantao [1 ]
Yang, Han [1 ]
Ma, Yidan [1 ]
Cao, Yuan [1 ]
Xu, Dan [2 ,3 ]
Liu, Xili [1 ,2 ]
Xu, Gong [1 ,2 ]
机构
[1] Northwest A&F Univ, Coll Plant Protect, Key Lab Plant Protect Resources & Pest Management, Minist Educ, Yangling 712100, Shaanxi, Peoples R China
[2] State Key Lab Crop Stress Biol Arid Areas, Key Lab Bot Pesticide R&D Shaanxi Prov, Yangling 712100, Shaanxi, Peoples R China
[3] Northwest A&F Univ, Coll Chem & Pharm, Shaanxi Key Lab Nat Prod & Chem Biol, Yangling 712100, Shaanxi, Peoples R China
基金
中国国家自然科学基金;
关键词
pyrazol-5-yl-benzamide; thiocyanato group; fungicidal activity; succinate dehydrogenase inhibitors; homology modeling; molecular docking; VALSA CANKER; APPLE;
D O I
10.1021/acs.jafc.3c04869
中图分类号
S [农业科学];
学科分类号
09 ;
摘要
In an effort to promote the development of new fungicides, a series of 48 novel N-(1-methyl-4-thiocyanato-1H-pyrazol-5-yl)-benzamide derivatives A1-A36 and B1-B12 were designed and synthesized by incorporating a thiocyanato group into the pyrazole ring, and their fungicidal activities were evaluated against Sclerotinia sclerotiorum, Valsa mali, Botrytis cinerea, Rhizoctonia solani, and Phytophthora capsici. In the in vitro antifungal/antioomycete assay, many of the target compounds exhibited good broad-spectrum fungicidal activities. Among them, compound A36 displayed the best antifungal activity against V. mali with an EC50 value of 0.37 mg/L, which was significantly higher than that of the positive controls fluxapyroxad (13.3 mg/L) and dimethomorph (10.3 mg/L). Meanwhile, compound B6 exhibited the best antioomycete activity against P. capsici with an EC50 value of 0.41 mg/L, which was higher than that of azoxystrobin (29.2 mg/L) but lower than that of dimethomorph (0.13 mg/L). Notably, compound A27 displayed broad-spectrum inhibitory activities against V. mali, B. cinerea, R. solani, S. sclerotiorum, and P. capsici with respective EC50 values of 0.71, 1.44, 1.78, 0.87, and 1.61 mg/L. The in vivo experiments revealed that compounds A27 and B6 presented excellent protective and curative efficacies against P. capsici, similar to that of the positive control dimethomorph. Scanning electron microscopy (SEM) and transmission electron microscopy (TEM) analyses showed that compound B6 could change the mycelial morphology and severely damage the ultrastructure of P. capsici. The results of the in vitro SDH enzymatic inhibition experiments indicated that compounds A27 and B6 could effectively inhibit the activity of P. capsici SDH (PcSDH). Furthermore, molecular docking analysis demonstrated significant hydrogen bonds and Pi-S bonding between the target compounds and the key amino acid residues of PcSDH, which could explain the probable mechanism of action. Collectively, these studies provide a valuable approach to expanding the fungicidal spectrum of pyrazol-5-yl-benzamide derivatives.
引用
收藏
页码:17700 / 17712
页数:13
相关论文
共 42 条
  • [31] Synthesis of some novel C-5 and N-3 substituted 2-(2-hydroxyphenylimino)thiazolidin-4-one derivatives with broad-spectrum antimicrobial activity
    N. C. Desai
    H. M. Satodiya
    K. M. Rajpara
    V. V. Joshi
    H. V. Vaghani
    Medicinal Chemistry Research, 2013, 22 : 6063 - 6077
  • [32] Synthesis of some novel C-5 and N-3 substituted 2-(2-hydroxyphenylimino)thiazolidin-4-one derivatives with broad-spectrum antimicrobial activity
    Desai, N. C.
    Satodiya, H. M.
    Rajpara, K. M.
    Joshi, V. V.
    Vaghani, H. V.
    MEDICINAL CHEMISTRY RESEARCH, 2013, 22 (12) : 6063 - 6077
  • [33] Discovery of 3-(4-methanesulfonylphenoxy)-N-[1-(2-methoxy-ethoxymethyl)-1H-pyrazol-3-yl]-5-(3-methylpyridin-2-yl)-benzamide as a novel glucokinase activator (GKA) for the treatment of type 2 diabetes mellitus
    Park, Kaapjoo
    Lee, Byoung Moon
    Hyun, Kwan Hoon
    Lee, Dong Hoon
    Choi, Hyun Ho
    Kim, Hyunmi
    Chong, Wonee
    Kim, Kyeong Bae
    Nam, Su Youn
    BIOORGANIC & MEDICINAL CHEMISTRY, 2014, 22 (07) : 2280 - 2293
  • [34] Synthesis and structure–activity relationships of novel lincomycin derivatives part 3: discovery of the 4-(pyrimidin-5-yl)phenyl group in synthesis of 7(S)-thiolincomycin analogs
    Yoshinari Wakiyama
    Ko Kumura
    Eijiro Umemura
    Satomi Masaki
    Kazutaka Ueda
    Yasuo Sato
    Takashi Watanabe
    Yoko Hirai
    Keiichi Ajito
    The Journal of Antibiotics, 2017, 70 : 52 - 64
  • [35] Novel heteroleptic iridium(III) complexes with a 2-(1H-pyrazol-5-yl)pyridine derivative containing a carbazole group as ancillary ligand: Synthesis and application for polymer light-emitting diodes
    Tang, Huaijun
    Wei, Liying
    Wang, Jianbin
    Li, Yanhu
    Wu, Hongbin
    Yang, Wei
    Cao, Yong
    SYNTHETIC METALS, 2014, 187 : 209 - 216
  • [36] Synthesis and structure-activity relationships of novel lincomycin derivatives part 3: discovery of the 4-(pyrimidin-5-yl)phenyl group in synthesis of 7(S)-thiolincomycin analogs
    Wakiyama, Yoshinari
    Kumura, Ko
    Umemura, Eijiro
    Masaki, Satomi
    Ueda, Kazutaka
    Sato, Yasuo
    Watanabe, Takashi
    Hirai, Yoko
    Ajito, Keiichi
    JOURNAL OF ANTIBIOTICS, 2017, 70 (01): : 52 - 64
  • [37] Discovery of N-(1,3,4-thiadiazol-2-yl)benzamide derivatives containing a 6,7-methoxyquinoline structure as novel EGFR/HER-2 dual-target inhibitors against cancer growth and angiogenesis
    Li, Xin-yang
    Wang, De-pu
    Li, Shuai
    Xue, Wen-han
    Qian, Xin-hua
    Liu, Kai-li
    Li, Yu-heng
    Lin, Qi-qi
    Dong, Gang
    Meng, Fan-hao
    Jian, Ling-yan
    BIOORGANIC CHEMISTRY, 2022, 119
  • [38] Structural optimization of 4-(imidazol-5-yl)pyridine derivatives affords broad-spectrum anticancer agents with selective B-RAFV600E/p38a kinase inhibitory activity: Synthesis, in vitro assays and in silico study
    Ali, Eslam M. H.
    Mersal, Karim, I
    Ammar, Usama M.
    Zaraei, Seyed-Omar
    Abdel-Maksoud, Mohammed S.
    El-Gamal, Mohammed, I
    Haque, Md Mamunul
    Das, Tanuza
    Kim, Eunice EunKyeong
    Lee, Jun-Seok
    Lee, Kwan Hyi
    Kim, Hee-Kwon
    Oh, Chang-Hyun
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2022, 171
  • [39] Discovery and in vitro and in vivo profiles of N-ethyl-N-[2-[3-(5-fluoro-2-pyridinyl)-1H-pyrazol-1-yl]ethyl]-2-(2H-1,2,3-triazol-2-yl)-benzamide as a novel class of dual orexin receptor antagonist
    Suzuki, Ryo
    Nozawa, Dai
    Futamura, Aya
    Nishikawa-Shimono, Rie
    Abe, Masahito
    Hattori, Nobutaka
    Ohta, Hiroshi
    Araki, Yuko
    Kambe, Daiji
    Ohmichi, Mari
    Tokura, Seiken
    Aoki, Takeshi
    Ohtake, Norikazu
    Kawamoto, Hiroshi
    BIOORGANIC & MEDICINAL CHEMISTRY, 2015, 23 (06) : 1260 - 1275
  • [40] Discovery and in vitro and in vivo profiles of N-ethyl-N-[2-[3-(5-fluoro-2-pyridinyl)-1H-pyrazol-1-yl]ethyl]-2-(2H-1,2,3-triazol-2-yl)-benzamide (TASP0428980) as a novel class of dual orexin receptor antagonist
    Suzuki, Ryo
    Nozawa, Dai
    Futamura, Aya
    Shimono, Rie
    Abe, Masahito
    Hattori, Nobutaka
    Ohta, Hiroshi
    Araki, Yuko
    Kambe, Daiji
    Ohmichi, Mari
    Tokura, Seiken
    Aoki, Takeshi
    Ohtake, Norikazu
    Kawamoto, Hiroshi
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2016, 251